COVID-19

Liam Townsend, MD, and his co-authors looked at a number of measures of recovery for 153 patients who were followed in an outpatient clinic a median of 75 days after their COVID-19 diagnoses.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on whether any unforeseen problems have arisen during the first wave of COVID-19 vaccinations at long-term care facilities.

Approximately one-third of children with COVID-19 are asymptomatic, according to a study conducted by researchers at the University of Alberta.

As patients with HIV are living longer, they are also being diagnosed with chronic conditions that have become increasingly common in recent decades, putting them at higher risk of COVID-19 hospitalization and death.

Pharmacy Times® interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on the first wave of COVID-19 vaccine administration at long-term care facilities across the country.

Study finds the COVID-19 pandemic has drastically improved the quality and convenience of virtual cancer care.

There is particular interest in monoclonal antibody agents to determine whether their immune suppressive effects can reduce the immediate and long-term impact of COVID-19.

COVID-19 has been found in the brain post-mortem.

Moderna, Inc has also announced temporary authorization of its COVID-19 vaccine in Switzerland.

The study authors said their main hypothesis for the higher prevalence of olfactory dysfunction in mild COVID-19 cases was based on differences in the immune response to the infection.

With approximately 328 million people currently living in the United States, it will take an army of health care professionals to vaccinate the country against COVID-19.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

The online guide places a special emphasis on security, storage, and handling.

In the past week, Moderna and AstraZeneca have collectively announced multiple authorizations for use of their respective vaccines.

Despite the concerns that may come along with mutations of the SARS-CoV-2 virus, experts say the new strains do not call for any new prevention strategies.

In a recent study at the National Institutes of Health, researchers consistently observed signs of damage on the brain scans of patients who died after contracting COVID-19.

Pralatrexate, a lymphoma drug, outperformed remdesivir in treating COVID-19 in a lab experiment.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

Socioeconomic and racial health disparities contribute to worse cancer and COVID-19 outcomes.

A recent study investigated the existence of “pharmacy deserts” in Los Angeles County in relation to the social determinants of health that show which communities have the greatest need for pharmacy access.

The company began administering COVID-19 vaccines to residents and staff at long-term care facilities in late December as part of the CDC Pharmacy Partnership for Long-term Care Program.

Despite fringe conspiracy theories that circulated online, COVID-19 carries a greater risk of health problems than the flu.

The event focused on the care, compassion, and connections the are important to pharmacists, and how the profession can tackle challenges such as payment reform and public awareness.

Soon, all Americans will be able to receive the vaccine at pharmacies including CVS and Walgreens, and their primary care provider's office.

Reports indicate a mortality rate of up to 28% among solid organ transplant patients hospitalized with coronavirus disease 2019.